The cardiac monitoring and cardiac rhythm management devices market is fragmented. Vendors are deploying growth strategies such as continuously undergoing M&A to compete in the market.
The cardiac monitoring and cardiac rhythm management devices market size is expected to grow by USD 5.52 bn from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 4.5% during the forecast period, according to Technavio.
Get a comprehensive report summary describing the market size and forecast along with research methodology. Request a FREE sample report
Cardiac Monitoring and Cardiac Rhythm Management Devices Market 2022-2026: Scope
The cardiac monitoring and cardiac rhythm management devices market report covers the following areas:
- Cardiac Monitoring and Cardiac Rhythm Management Devices Market size
- Cardiac Monitoring and Cardiac Rhythm Management Devices Market trends
- Cardiac Monitoring and Cardiac Rhythm Management Devices Market industry analysis
Cardiac Monitoring and Cardiac Rhythm Management Devices Market 2022-2026: Vendor Analysis
We provide a detailed analysis of around 25 vendors operating in the cardiac monitoring and cardiac rhythm management devices market, including Abbott Laboratories, Abiomed Inc., ACS Diagnostics Inc., Asahi Kasei Corp., BioTelemetry Inc., BIOTRONIK SE and Co KG, Boston Scientific Corp., Fukuda Denshi Co. Ltd., GE Healthcare Inc., HILL ROM HOLDINGS Inc., InfoBionic Inc., Integrated Sensing Systems Inc., iRhythm Technologies Inc., Koninklijke Philips NV, Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., OSI Systems Inc., Preventice Solutions Inc., and SCHILLER AG. The key offerings of some of these vendors are listed below:
- Abbott Laboratories – The company offers Cardiac Resynchronization Therapy (CRT) devices, catheters, connectivity and remote care Implantable Cardioverter Defibrillators (ICD) and others under cardiac rhythm management devices.
- Abiomed Inc. – The company offers heart pumps such as Impella 2.5, Impella CP, and Impella 5.0. It provides SmartAssist technology, which gives medical providers insights to help them improve patient outcomes.
- Asahi Kasei Corp. – The company offers defibrillation and cardiac monitoring devices and software for observation of heart activity to determine the health of the heart.
- BIOTRONIK SE and Co KG – The company offers a wide range of devices under cardiac rhythm management, such as Arrhythmia Monitoring, Bradycardia, and Tachycardia.
- Boston Scientific Corp. – The company offers HeartLogic Heart, LUX-DX ICM, and EMBLEM MRI S-ICD under cardiac rhythm management.
Cardiac Monitoring and Cardiac Rhythm Management Devices Market 2022-2026: Segmentation
- Product
- Cardiac Rhythm Management Devices: The cardiac rhythm management devices segment will contribute the highest market share growth. Cardiac rhythm management devices include defibrillators, which restore the normal heartbeat by delivering a shock or an electric pulse to the patient’s heart.
- Cardiac Monitoring Devices
- Geography
- North America: The region will contribute the highest market share growth during the forecast period. This growth is attributed to factors such as high healthcare expenditure on CVDs.
- Europe
- Asia
- Rest Of World (ROW)
Learn more about the contribution of each segment of the market. Download a FREE Sample Report
Cardiac Monitoring and Cardiac Rhythm Management Devices Market 2022-2026: Key Highlights
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will assist cardiac monitoring and cardiac rhythm management devices market growth during the next five years
- Estimation of the cardiac monitoring and cardiac rhythm management devices market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the cardiac monitoring and cardiac rhythm management devices market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of cardiac monitoring and cardiac rhythm management devices market vendors
